Money• June 30, 2026 • By Staff Writer

How most-favored-nation pricing is reshaping generic drug economics, according to Dr. Reddy’s finance director

Most-Favored-Nation pricing is pressuring generic drug margins. Dr. Reddy’s finance director shares the cost optimization and supply chain strategies manufacturers are using to sustain affordability.

This post was originally published on this site.

About the Author

Staff Writer

Staff Writer

Written by a Staff Writer at this publication, this article reflects the work of our editorial team. Our staff writers cover topics locally and nationally to keep you informed on the top stories of our time.

Leave a Reply

Your email address will not be published. Required fields are marked *